Skip to content

ENDS IN 24 MONTHS

The Purpose Of This Award Is To Advance The Development Of Isola'S Nebulization Therapy, A Medical Counterm…

Office of Assistant Secretary for Preparedness and Response · BARDA - ASPR / DAAPPO / BARDA DCMA

Open on USAspending ↗Look for the recompete on SAM.gov ↗
Sign in to track this contract

CAN YOU BID THIS?

Open competition

  • Last award was competed and not reserved for a program, so any eligible firm can bid.

Sign in and add a company profile to get a call for your firm.

Pro adds how many offers it drew last time to this read.

Check before you spend bid hours

  • Dates and values are from USAspending as of Oct 20, 2026. Confirm the incumbent's end date with the contracting office or a Sources Sought before committing bid hours.
Incumbent
ISOLA THERAPEUTICS INC
Small business · UEI M3QDM72NME75
Recompete expected (last option ends)
Oct 31, 2028
Current option period ends
Oct 31, 2028
Potential value
$7.5M ($7.5M obligated)
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
PSC
AN13 · Health R&D Services; Health Care Services; Experimental Development
Set-aside
No set-aside
Vehicle
Standalone contract
Award type
Definitive Contract
Place of performance
MN
Solicitation ID
EZ-BAA-22-100-SOL-00003
PIID
75A50126C00005

Last competition, subcontractors and incumbent

See how many offers this contract drew last time, who the incumbent subcontracts to, and the rest of the incumbent's expiring portfolio.

Unlock with Pro — $39 / mo

More expiring contracts from this office

Source: USAspending.gov prime award summary (FPDS), last modified Apr 27, 2026. Periods of performance change when options are exercised or the contract is modified; confirm on the source record before acting.